Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept Study to Evaluate the Clinical Safety and Efficacy of Ex-vivo Cultivated Allogenic Limbal Stem Cell Transplantation for Treatment of Superficial Corneal Pathologies".

NCT04932629 is registered in ClinicalTrials.gov with L.V. Prasad Eye Institute as lead sponsor.

NCT NCT04932629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04932629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept Study to Evaluate the Clinical Safety and Efficacy of Ex-vivo Cultivated Allogenic Limbal Stem Cell Transplantation for Treatment of Superficial Corneal Pathologies".
Lead sponsor
L.V. Prasad Eye Institute
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2021
Completion date
January 31, 2023
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

corneal scars and opacities